China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025)
China Pharma Holdings (CPHI) Share-based Compensation Growth (1y) (2011 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.94 Bn | 42.97 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.08 Bn | 39.43 Bn | 2.15 Bn | 5.26% |
| 3 | Zoetis | 31.54 Bn | 29.87 Bn | 1.05 Bn | -36.59% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | -0.11% |
| 5 | United Therapeutics | 22.12 Bn | 19.46 Bn | 683.80 Mn | -49.74% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -18.06% |
| 7 | Neurocrine Biosciences | 15.50 Bn | 15.11 Bn | 935.80 Mn | 23.11% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | -65.00% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.96 Bn | - | - |
| 10 | China Pharma Holdings | 42.14 Mn | 41.84 Mn | 83,566.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 563.95% |
| Dec 31, 2024 | 668.29% |
| Mar 31, 2024 | 110.00% |
| Dec 31, 2023 | -140.70% |
| Sep 30, 2023 | 850.54% |
| Jun 30, 2023 | -345.54% |
| Mar 31, 2023 | 116.67% |
| Dec 31, 2022 | 194,014.07% |
| Sep 30, 2022 | 1,212.08% |
| Mar 31, 2014 | -43.47% |
| Jun 30, 2013 | -365.73% |
| Mar 31, 2013 | 300.95% |
| Jun 30, 2012 | 112.72% |
| Mar 31, 2012 | 34.83% |
| Dec 31, 2011 | -10.53% |
| Sep 30, 2011 | -5.58% |